NGM Updated its IPO filing to include an estimated price range of $14 to $16 per share. If all available shares are purchased, the IPO will raise more than $122 Million. The company intends to... read more
Saama Technologies, Inc. (“Saama”), a leading clinical data analytics platform firm, announced on 3/25/19 that it has closed a $40 million financing with Perceptive Advisors. The new funding will... read more
Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, announced today it has filed a registration... read more
